They often treat SOC 2 as if it were the final assurance state and then add HITRUST without first validating whether the organisation is actually handling PHI correctly. The better approach is to map existing controls to HIPAA, close the real gaps, and only then scope HITRUST to the buyer's requirement.
Why This Matters for Security Teams
healthcare compliance planning goes wrong when teams treat SOC 2 as proof that the organisation is ready for regulated health data handling. It is not. SOC 2 can demonstrate that controls exist and are operating, but it does not validate whether the organisation is correctly scoping PHI, meeting HIPAA obligations, or aligning buyer-driven HITRUST expectations to actual workflows. The result is a gap between audit posture and real patient-data risk.
This is especially dangerous in healthcare because identity sprawl, third-party access, and mis-scoped integrations often create hidden exposure. NHI Management Group has highlighted how hard this problem becomes once organisations lose visibility into service accounts and API keys, with only 5.7% reporting full visibility into service accounts in the Ultimate Guide to NHIs — Regulatory and Audit Perspectives. When those identities can touch clinical, billing, or analytics systems, compliance planning has to start with actual data handling, not certification status. Current guidance from NIST Cybersecurity Framework 2.0 also reinforces that governance should map to risk and business context, not just attestations. In practice, many security teams discover the mismatch only after a customer questionnaire or legal review exposes that the controls were never mapped to PHI workflows.
How It Works in Practice
The better sequence is straightforward: first determine whether the organisation actually creates, receives, stores, transmits, or can access PHI; then map the existing control set to HIPAA; then identify the delta before scoping HITRUST. That avoids paying for a framework that does not match the real operating model. If a team jumps from SOC 2 to HITRUST, it often overbuilds controls in low-risk areas while missing the more important ones, such as access governance, audit logging, vendor oversight, and key management for systems that touch patient data.
Practitioners should translate SOC 2 evidence into healthcare-specific questions:
- Which systems are in scope for PHI, and who or what can access them?
- Which identities are human, which are NHIs, and which have privileged access?
- Do service accounts, API keys, and tokens follow lifecycle controls aligned to the Top 10 NHI Issues?
- Are access reviews, logging, and revocation processes strong enough to satisfy buyer due diligence and HIPAA expectations?
For control design, use NIST SP 800-53 Rev 5 Security and Privacy Controls as a practical translation layer, then validate the resulting scope against healthcare contracts and actual data flows. HITRUST should come after the control baseline is understood, because the framework is meant to formalise and score maturity, not replace scoping discipline. These controls tend to break down when healthcare platforms rely on third-party integrations and unmanaged non-human identities, because the real PHI pathways are usually outside the original audit boundary.
Common Variations and Edge Cases
Tighter compliance sequencing often increases upfront assessment cost, requiring organisations to balance faster certification timelines against accurate PHI scoping. That tradeoff is unavoidable in healthcare, especially when a buyer demands HITRUST before procurement can proceed. Current guidance suggests that teams should distinguish between “compliance for sales” and “compliance for regulated data,” because those are not the same problem and rarely share identical scope.
There is also no universal standard for how much SOC 2 evidence can be reused for HITRUST. Some controls map cleanly, such as logging, change management, and incident response. Others need healthcare-specific interpretation, especially where BAAs, PHI retention, minimum necessary access, and subcontractor oversight are involved. The most common edge case is a SaaS platform that is SOC 2 certified but only processes PHI through a narrow workflow or a small set of integrations. In that case, the right move is not to expand HITRUST to the whole company by default, but to isolate the PHI boundary and assess the supporting identities, vendors, and data flows with precision.
Teams that skip this sequencing often end up with expensive control overlap and still fail due diligence because they never proved the organisation was handling PHI correctly in the first place. That is why Ultimate Guide to NHIs — Lifecycle Processes for Managing NHIs matters here: healthcare compliance is only as strong as the identities that move data through the environment.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
OWASP Non-Human Identity Top 10 and CSA MAESTRO address the attack and risk surface, while NIST CSF 2.0, NIST SP 800-63 and NIST AI RMF set the governance and control requirements practitioners need to meet.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST CSF 2.0 | GV.OC-01 | Healthcare compliance must start with business context and PHI scope. |
| NIST SP 800-63 | Identity assurance matters where users and NHIs access regulated health data. | |
| OWASP Non-Human Identity Top 10 | NHI-01 | Service accounts and API keys often create hidden PHI access paths. |
| NIST AI RMF | GOVERN | Governance is needed to align compliance claims with actual data handling. |
| CSA MAESTRO | Third-party and workload governance are central in healthcare integrations. |
Verify identity strength and lifecycle controls for anyone or anything touching PHI.
Related resources from NHI Mgmt Group
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on August 28, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org
